We represented TT Capital Partners, a value-add healthcare investor that provides capital, expertise and insight to healthcare technology and services companies, in its recapitalization of Pyx Health, a tech-enabled services company that provides health plans and their members an innovative, scalable solution that uniquely reduces loneliness and social isolation. Terms of the transaction were not disclosed.

Deal Recognition

This deal was recognized as a winner in the Healthcare/Life Sciences Deal of the Year ($50MM to $100MM) category at the 23rd Annual M&A Advisor Awards. To read more about the awards, click here.

The deal had been named a finalist in the following categories for the 23rd Annual M&A Advisor Awards in 2024:

  • Healthcare/Life Sciences Deal of the Year ($50MM to $100MM)
  • Private Equity Deal of the Year ($75MM to $100MM)

Bass, Berry & Sims had four transactions recognized among nine different categories for The M&A Advisor Awards in 2024.